RCKT•benzinga•
Cantor Fitzgerald Maintains Overweight on Rocket Pharmaceuticals, Raises Price Target to $30
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2025 by benzinga